Parikh Anand Kiran
SEC insider (Form 3/4/5 filer). CIK 0002111813. President and CEO at Faeth Therapeutics, Inc. (FTH). 12 reported Form 4/5 transactions since Sep 2024; latest on Jul 21, 2026. Located in AUSTIN, TX.
Companies Parikh Anand Kiran has filed insider reports for
- Faeth Therapeutics, Inc. (FTH): Director, Officer, President and CEO
Parikh Anand Kiran
CIK: 0002111813
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Faeth Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jul 21, 2026FTH
Faeth Therapeutics, Inc.
AwardDirectPerformance-Based Stock Option (right to buy)
398K shares- - Jun 22, 2026FTH
Faeth Therapeutics, Inc.
PurchaseDirect2.8K shares at avg. $19.76$55K - Jun 22, 2026FTH
Faeth Therapeutics, Inc.
ExerciseDirect45.3K shares at avg. $1.16$52K - Jun 22, 2026FTH
Faeth Therapeutics, Inc.
ExerciseDirect8.2K shares at avg. $1.16$10K - Jun 15, 2026FTH
Sensei Biotherapeutics, Inc.
ConversionDirect761.4K shares- - Feb 19, 2026SNSE
Sensei Biotherapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
1.2M shares- - Feb 17, 2026FTH
Sensei Biotherapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
136.9K shares- - Feb 17, 2026FTH
Sensei Biotherapeutics, Inc.
AwardDirectSeries B Preferred Stock
761 shares- - Feb 17, 2026FTH
Sensei Biotherapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
12.3K shares- - Feb 17, 2026SNSE
Sensei Biotherapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
92.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 21, 2026 | FTH Faeth Therapeutics, Inc. | Award Performance-Based Stock Option (right to buy) | 398,018 | - | - | Direct |
| Jun 22, 2026 | FTH Faeth Therapeutics, Inc. | Purchase | 2,806 | $19.76 | $55,447 | Direct |
| Jun 22, 2026 | FTH Faeth Therapeutics, Inc. | Exercise | 45,252 | $1.16 | $52,492 | Direct |
| Jun 22, 2026 | FTH Faeth Therapeutics, Inc. | Exercise | 8,213 | $1.16 | $9,527 | Direct |
| Jun 15, 2026 | FTH Sensei Biotherapeutics, Inc. | Conversion | 761,428 | - | $0 | Direct |
| Feb 19, 2026 |  SNSE Sensei Biotherapeutics, Inc. | Award Employee Stock Option (right to buy) | 1,239,305 | - | - | Direct |
| Feb 17, 2026 | FTH Sensei Biotherapeutics, Inc. | Award Employee Stock Option (right to buy) | 136,884 | - | - | Direct |
| Feb 17, 2026 | FTH Sensei Biotherapeutics, Inc. | Award Series B Preferred Stock | 761 | - | - | Direct |
| Feb 17, 2026 | FTH Sensei Biotherapeutics, Inc. | Award Employee Stock Option (right to buy) | 12,320 | - | - | Direct |
| Feb 17, 2026 | SNSE Sensei Biotherapeutics, Inc. | Award Employee Stock Option (right to buy) | 92,533 | - | - | Direct |
1-10 of 12 transactions